DNTech
PrivateLast Round
Early Funding
Apr 23, 2025
Company Overview
DNTech is a biotechnology company that develops rapid, portable, and automated detection kits for micro-organisms to ensure food safety in the agri-food industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNTech Comparables
Compare DNTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EW Group | 74% | |
| bioMérieux | 73% | |
| Neogen Corporation | 66% | |
DNTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 23, 2025 | ||||
| Grant | Nov 1, 2024 |
DNTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Île-de-France | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
Received grant funding from Bpifrance and Région Île-de-France.
DNTech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DNTech's valuation, stock price, and market status.